Rónán O'Caoimh1, Lucia Galluzzo2, Ángel Rodríguez-Laso3, Johan Van der Heyden4, Anette Hylen Ranhoff5, Maria Lamprini-Koula6, Marius Ciutan7, Luz López-Samaniego8, Laure Carcaillon-Bentata9, Siobhán Kennelly10, Aaron Liew10. 1. Health Service Executive of Ireland (Social Care Division) and National University of Ireland (Discipline of Medicine), Galway, Ireland - Health Service Executive of Ireland (Social Care Division) and National University of Ireland (Discipline of Medicine), Galway, Ireland. 2. Dipartimento Malattie Cardiovascolari, Dismetaboliche e Invecchiamento, Istituto Superiore di Sanità, Rome, Italy. 3. Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Getafe, Spain. 4. Sciensano, Brussels, Belgium. 5. Nasjonalt Folkehelseinstitutt (Norwegian Institute of Public Health), Oslo, Norway. 6. Society of Psychosocial Research and Intervention. Ionnina, Greece. 7. Scoala Nationala de Sanatate Publica, Management si Perfectionare in Domeniul Sanitar, Bucharest, Romania. 8. Fundación Progreso y Salud, Consejeria de Salud de la Junta de Andalucia, Sevilla, Spain. 9. Santé Publique, Saint Maurice, France. 10. Health Service Executive of Ireland (Social Care Division) and National University of Ireland (Discipline of Medicine), Galway, Ireland.
Abstract
INTRODUCTION: Although frailty is common among community-dwelling older adults, its prevalence in Europe and how this varies between countries is unclear. METHODS: A systematic review and meta-analysis of literature on frailty prevalence in 22 European countries involved in the Joint Action ADVANTAGE was conducted. RESULTS: Sixty-two papers, representing 68 unique datasets were included. Meta-analysis showed an overall estimated frailty prevalence of 18% (95% confidence interval, CI, 15-21%). The prevalence in community (n = 53) vs non-community based studies (n = 15) was 12% (95% CI 10-15%) and 45% (95% CI 27-63%), respectively. Pooled prevalence in community studies adopting a physical phenotype was 12% (95% CI 10-14%, n = 45) vs 16% (95% CI 7-29%, n = 8) for all other definitions. Sub-analysis of a subgroup of studies assessed as high-quality (n = 47) gave a pooled estimate of 17% (95% CI 13-21%). CONCLUSIONS: The considerable and significant heterogeneity found warrants the development of common methodological approaches to provide accurate and comparable frailty prevalence estimates at population-level.
INTRODUCTION: Although frailty is common among community-dwelling older adults, its prevalence in Europe and how this varies between countries is unclear. METHODS: A systematic review and meta-analysis of literature on frailty prevalence in 22 European countries involved in the Joint Action ADVANTAGE was conducted. RESULTS: Sixty-two papers, representing 68 unique datasets were included. Meta-analysis showed an overall estimated frailty prevalence of 18% (95% confidence interval, CI, 15-21%). The prevalence in community (n = 53) vs non-community based studies (n = 15) was 12% (95% CI 10-15%) and 45% (95% CI 27-63%), respectively. Pooled prevalence in community studies adopting a physical phenotype was 12% (95% CI 10-14%, n = 45) vs 16% (95% CI 7-29%, n = 8) for all other definitions. Sub-analysis of a subgroup of studies assessed as high-quality (n = 47) gave a pooled estimate of 17% (95% CI 13-21%). CONCLUSIONS: The considerable and significant heterogeneity found warrants the development of common methodological approaches to provide accurate and comparable frailty prevalence estimates at population-level.
Authors: Maria Gabriella Melchiorre; Barbara D'Amen; Sabrina Quattrini; Giovanni Lamura; Marco Socci Journal: Int J Environ Res Public Health Date: 2022-06-16 Impact factor: 4.614
Authors: Eduardo Carballeira; Karla C Censi; Ana Maseda; Rocío López-López; Laura Lorenzo-López; José C Millán-Calenti Journal: Sci Rep Date: 2021-06-28 Impact factor: 4.379